Australia, CBD, Europe, HT Premium, Investment, Medical

Interview: Boaz Wachtel, CresoPharma

Boaz Wachtel, President of Creso Pharma

‘Democratization of knowledge’ fuels demand

Boaz Wachtel is chairman and co-founder of CresoPharma, a nutraceuticals company which debuted on the Australian Stock Exchange (ASX) this autumn. He is a certified clinical research manager and holds an MA in management and marketing from the University of Maryland. He was co-founder and former managing director of MMJ Phytotech, Australia’s first publicly traded medical cannabis company.

You need to login to view the rest of the content. Please . Not a Member? Join Us

Get Hemp Industry Updates

* indicates required

Do you want event updates?